Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2

被引:26
作者
Abbasi, Asim Z. [1 ]
Kiyani, Dania A. [1 ]
Hamid, Syeda M. [1 ]
Saalim, Muhammad [1 ,2 ]
Fahim, Ammad [3 ]
Jalal, Nasir [1 ,4 ]
机构
[1] PsiMega2 Pvt Ltd, Islamabad, Pakistan
[2] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China
[3] Natl Univ Med Sci, Rawalpindi, Punjab, Pakistan
[4] Nanjing Univ Informat Sci & Technol, 219 Ningliu Rd, Nanjing, Jiangsu, Peoples R China
关键词
coronavirus; COVID-19; differential gene expression; SARS-CoV-2; TMPRSS2; blockers; inhibitors; viral entry; SERINE-PROTEASE; PROSTATE-CANCER; MERS-COV; RECEPTOR; CORONAVIRUS; EXPRESSION; INFECTION; PNEUMONIA; COVID-19; CLONING;
D O I
10.1002/jmv.26911
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Epidemiological data shows a discrepancy in COVID-19 susceptibility and outcomes with some regions being more heavily affected than others. However, the factors that determine host susceptibility and pathogenicity remain elusive. An increasing number of publications highlight the role of Transmembrane Serine Protease 2 (TMPRSS2) in the susceptibility of the host cell to SARS-CoV-2. Cleavage of viral spike protein via the host cell's TMPRSS2 enzyme activity mediates viral entry into the host cell. The enzyme synthesis is regulated by the TMPRSS2 gene, which has also been implicated in the entry mechanisms of previously reported Coronavirus infections. In this review, we have investigated the pathogenicity of SARS-CoV-2 and disease susceptibility dependence on the TMPRSS2 gene as expressed in various population groups. We further discuss how the differential expression of this gene in various ethnic groups can affect the SARS-CoV-2 infection and Coronavirus disease (COVID)-19 outcomes. Moreover, promising new TMPRSS2 protease blockers and inhibitors are discussed for COVID-19 treatment.
引用
收藏
页码:4205 / 4218
页数:14
相关论文
共 126 条
[71]   Androgen receptor and androgen-dependent gene expression in lung [J].
Mikkonen, Laura ;
Pihlajamaa, Paivi ;
Sahu, Biswajyoti ;
Zhang, Fu-Ping ;
Janne, Olli A. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 317 (1-2) :14-24
[72]  
MOEIN S, 2020, MOL CELL, V10, P944, DOI DOI 10.1002/ALR.22587
[73]   Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532) [J].
Montopoli, M. ;
Zumerle, S. ;
Vettor, R. ;
Rugge, M. ;
Zorzi, M. ;
Catapano, C., V ;
Carbone, G. M. ;
Cavalli, A. ;
Pagano, F. ;
Ragazzi, E. ;
Prayer-Galetti, T. ;
Alimonti, A. .
ANNALS OF ONCOLOGY, 2020, 31 (08) :1040-1045
[74]   The 1918 influenza pandemic: Lessons for 2009 and the future [J].
Morens, David M. ;
Taubenberger, Jeffery K. ;
Harvey, Hillery A. ;
Memoli, Matthew J. .
CRITICAL CARE MEDICINE, 2010, 38 :E10-E20
[75]  
National Library of Medicine (U.S.), 2020, EVALUATING EFFICACY
[76]  
National Library of Medicine (U.S.), 2020, IMPACT CAMOSTAT MESI
[77]   Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression [J].
Nelson, PS ;
Gan, L ;
Ferguson, C ;
Moss, P ;
Gelinas, R ;
Hood, L ;
Wang, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3114-3119
[78]   Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2 [J].
Netland, Jason ;
Meyerholz, David K. ;
Moore, Steven ;
Cassell, Martin ;
Perlman, Stanley .
JOURNAL OF VIROLOGY, 2008, 82 (15) :7264-7275
[79]   Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations [J].
Ortiz-Fernandez, Lourdes ;
Sawalha, Amr H. .
GENES AND IMMUNITY, 2020, 21 (04) :269-272
[80]   Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection [J].
Padmanabhan, Pranesh ;
Desikan, Rajat ;
Dixit, Narendra M. .
PLOS COMPUTATIONAL BIOLOGY, 2020, 16 (12)